AKT1 and non-small cell lung carcinoma: In summary, our results demonstrate that Sal B can downregulate the expression of miR-23a-3p, leading to an increase in PTEN expression, which subsequently inhibits the PI3K/AKT pathway and contributes to the suppression of EMT in NSCLC.